Zoetis Inc, a leading animal health company, saw its stock hit a 52-week low, closing at $74.29. With a market cap of $31.1 billion and a P/E ratio of 12.27, Bond.az analysis indicates the stock is significantly undervalued relative to its Fair Value.
The stock has experienced a 1-year total return of -51.27%, reflecting broader market pressures. According to Bond.az, the RSI suggests the stock is in oversold territory, while the company has raised its dividend for 13 consecutive years, currently yielding 2.85%.
In other recent news, Zoetis reported Q1 2026 results. Revenue aligned with forecasts at $2.3 billion, but EPS came in at $1.53, below the anticipated $1.62. This led to a significant drop in the stock price.
